- Biogen Idec Inc is pricing its newly-approved long-acting hemophilia drug to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.
WASHINGTON - President Barack Obama mounted a vigorous effort on Thursday to show his signature healthcare law is working and dismissed Republican critics who are using flaws in Obamacare to campaign for ousting Democrats from the U.S. Congress in November. | Video
(This story from April 15 corrects name of researcher to Breiter, instead of Beiter, throughout story)
NEW YORK (Reuters Health) - For people recently diagnosed with type 2 diabetes, eating lots of olive oil, fish and whole grains slows progression of the disease more than restricting fat, according to a new analysis.
WASHINGTON - In an expected move, the U.S. Department of Agriculture on Friday announced new measures to combat the spread of disease in the U.S. pig population.
LONDON - The negative social, physical and mental health effects of childhood bullying are still evident nearly 40 years later, according to research by British psychiatrists.
- The U.S. Food and Drug Administration warned that a common surgical procedure used to remove uterine fibroids could spread undetected uterine cancer.
- Roughly 12 million adults who visit U.S. doctors' offices and other outpatient settings, or one in 20, are misdiagnosed every year, a new study has found, and half of those errors could lead to serious harm.
NEW YORK (Reuters Health) - Dermatologists tend to prescribe more expensive medications when they also give their patients drug samples, according to a new U.S. study.
A series that looks at all facets of cancer, written by Debra Sherman, a stage 4 lung cancer patient. Debra covered the health beat for Reuters for more than a decade and is using her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article